Hyphens Pharma International Limited (SGX:1J5)
0.3100
-0.0250 (-7.46%)
At close: Aug 14, 2025
SGXC:1J5 Revenue
Hyphens Pharma International had revenue of 44.77M SGD in the quarter ending June 30, 2025, a decrease of -13.32%. This brings the company's revenue in the last twelve months to 185.32M, down -5.22% year-over-year. In the year 2024, Hyphens Pharma International had annual revenue of 195.42M with 14.55% growth.
Revenue (ttm)
185.32M
Revenue Growth
-5.22%
P/S Ratio
0.48
Revenue / Employee
398.53K
Employees
474
Market Cap
89.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 195.42M | 24.83M | 14.55% |
Dec 31, 2023 | 170.60M | 8.28M | 5.10% |
Dec 31, 2022 | 162.32M | 36.43M | 28.94% |
Dec 31, 2021 | 125.88M | 4.91M | 4.06% |
Dec 31, 2020 | 120.98M | 1.54M | 1.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DBS Group Holdings | 22.10B |
Oversea-Chinese Banking Corporation | 13.72B |
Singapore Telecommunications | 14.13B |
United Overseas Bank | 13.32B |
Singapore Technologies Engineering | 11.67B |
Jardine Matheson Holdings | 45.30B |
Singapore Airlines | 19.54B |
Wilmar International | 88.29B |